£64.88

Springer Prevention of Bone Metastases: 192 (Recent Results in Cancer Research, 192)

Price data last checked 55 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 36 days • 36 data points (No recent data available)

Historical
Generating forecast...
£76.39 £31.08 £40.97 £50.85 £60.74 £70.62 £80.51 25 January 2026 02 February 2026 11 February 2026 20 February 2026 01 March 2026

Price Distribution

Price distribution over 36 days • 7 price levels

Days at Price
Current Price
7 days 10 days 1 day 5 days 1 day · current 5 days 7 days 0 3 5 8 10 £35 £52 £59 £62 £65 £70 £76 Days at Price

Price Analysis

Most common price: £52 (10 days, 27.8%)

Price range: £35 - £76

Price levels: 7 different prices over 36 days

Description

Bone metastases continue to be a major cause of morbidity in cancer patients, but improved understanding of the biology of bone metastases has led to the identification of drugs that are of potential value in not only their treatment but also their prevention. This book, written by recognized experts in the field, provides a detailed overview of current knowledge on this subject. One important focus of the book is the efficacy of bisphosphonates in preventing bone metastases in patients with breast, lung, and prostate cancer and disease progression in cases of multiple myeloma. The combined use of bisphosphonates and cytostatics is also discussed, with a report on first clinical data. Further topics addressed include the significance of the bone microenvironment, special issues in the elderly patient, the use of bone turnover markers, and initial findings obtained with denosumab.

Product Specifications

Format
Paperback
Domain
Amazon UK
Publication Date
22 February 2014
Listed Since
13 February 2014

Barcode

No barcode data available

Similar Products You Might Like

Springer Prevention of Bone Metastases - Cancer Research 192
100% match

Springer Prevention of Bone Metastases - Cancer Research 192

Springer

£102.86 01 Mar 2026
Bone Cancer: Progression and Therapeutic Approaches
94% match

Bone Cancer: Progression and Therapeutic Approaches

Academic Press

£69.84 24 Feb 2026
Bone Cancer: Primary Bone Cancers and Bone Metastases
94% match

Bone Cancer: Primary Bone Cancers and Bone Metastases

Academic Press

£102.19 25 Feb 2026
Management of Bone Metastases: A Multidisciplinary Guide
94% match

Management of Bone Metastases: A Multidisciplinary Guide

Springer

£53.54 06 Mar 2026
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
94% match

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Academic Press

£166.49 25 Jan 2026
Springer Bone Metastases: A Translational and Clinical Approach
93% match

Springer Bone Metastases: A Translational and Clinical Approach

Springer

£113.97 01 Mar 2026
Bone Metastasis: Experimental and Clinical Therapeutics (Cancer Drug Discovery and Development)
93% match

Bone Metastasis: Experimental and Clinical Therapeutics (Cancer Drug Discovery and Development)

Humana

£98.17 24 Feb 2026
Humana Bone Metastasis - Cancer Drug Discovery and Development
93% match

Humana Bone Metastasis - Cancer Drug Discovery and Development

Humana

£43.71 23 Feb 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
92% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 06 Jan 2026
Metastatic Bone Disease: An Integrated Approach to Patient Care
92% match

Metastatic Bone Disease: An Integrated Approach to Patient Care

Springer

£71.28 28 Feb 2026
Springer - Signaling Pathways and Molecular Mediators in Metastasis
92% match

Springer - Signaling Pathways and Molecular Mediators in Metastasis

Springer

£114.94 20 Apr 2026
Metastasis of Breast Cancer: 11 (Cancer Metastasis - Biology and Treatment, 11)
92% match

Metastasis of Breast Cancer: 11 (Cancer Metastasis - Biology and Treatment, 11)

Springer

£80.61 12 Jan 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
92% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£99.53 25 Feb 2026
Bone Tumors: Evidence-based Approach in Diagnosis and Management
92% match

Bone Tumors: Evidence-based Approach in Diagnosis and Management

Springer

£100.43 09 Mar 2026
Metastasis of Breast Cancer: v. 11 (Cancer Metastasis - Biology and Treatment)
92% match

Metastasis of Breast Cancer: v. 11 (Cancer Metastasis - Biology and Treatment)

Springer

£38.79 21 Feb 2026
Experimental and Clinical Metastasis: A Comprehensive Review
92% match

Experimental and Clinical Metastasis: A Comprehensive Review

Springer

£60.00 02 Mar 2026
Biology and Management of Multiple Myeloma (Current Clinical Oncology)
92% match

Biology and Management of Multiple Myeloma (Current Clinical Oncology)

Humana

£67.40 09 Mar 2026
Prostate Cancer Prevention: 202 (Recent Results in Cancer Research, 202)
92% match

Prostate Cancer Prevention: 202 (Recent Results in Cancer Research, 202)

Springer

£74.85 26 Feb 2026
Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)
92% match

Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)

Springer

£75.66 01 Mar 2026
Genomic Instability and Cancer Metastasis: Mechanisms, Emerging Themes, and Novel Therapeutic Strategies: 20 (Cancer Metastasis - Biology and Treatment, 20)
92% match

Genomic Instability and Cancer Metastasis: Mechanisms, Emerging Themes, and Novel Therapeutic Strategies: 20 (Cancer Metastasis - Biology and Treatment, 20)

Springer

£75.84 01 Mar 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
92% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£84.29 08 Mar 2026
Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach
92% match

Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach

Springer

£82.74 01 Mar 2026
Myeloma Bone Disease (Current Clinical Oncology)
92% match

Myeloma Bone Disease (Current Clinical Oncology)

Humana

£139.86 21 Feb 2026
Horizons in Cancer Research. Volume 73: Volume 73
92% match

Horizons in Cancer Research. Volume 73: Volume 73

£116.24 11 Jan 2026